Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.
He X, He G, Chu Z, Wu H, Wang J, Ge Y, Shen H, Zhang S, Shan J, Peng K, Wei Z, Zou Y, Xu Y, Zhu Q.
He X, et al. Among authors: peng k.
J Med Chem. 2021 Dec 23;64(24):17950-17968. doi: 10.1021/acs.jmedchem.1c01305. Epub 2021 Dec 2.
J Med Chem. 2021.
PMID: 34854662